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702–9.Extracellular Volume and Cardiac Mechanics:
Have We Found a Missing Puzzle Piece?We have read with great interest the recent report
regarding increased cardiac extracellular volume
(ECV) and impaired left ventricular (LV) mechanics in
hypertensive patients (1). The study was innovative,
and it may provide answers to many questions about
left ventricular hypertrophy (LVH) and LV mechanics
in hypertension. There are several important topics
that deserve comment.
The investigators indicated that a small sample
size was an obstacle for the evaluation of different
effects: age, sex, diabetes, hypertension duration,
and antihypertensive treatment. However, it would
be useful to present at least the data regarding the
use of medications, especially those that block the
renin-angiotensin-aldosterone system or sympathetic
nervous system. Cardiac extracellular matrix is sig-
niﬁcantly inﬂuenced by these biohumoral systems, so
it is quite reasonable to hypothesize that these anti-
hypertensive drugs inﬂuence ECV. In the present
study, Kuruvilla et al. (1) reported that the non-LVH
patients had signiﬁcantly lower blood pressure levels
than the LVH subjects. It is possible that this group had
lower ECV because these patients were more often
treated with renin-angiotensin-aldosterone system
and sympathetic nervous system blockers.
Interestingly, the investigators did not provide
data on the correlation between blood pressure level
and ECV or native T1, a measurement of myocardial
ﬁbrosis. These results would be of interest because
blood pressure could be a signiﬁcant confounding
variable in the relationship between ECV and LVH or
between ECV and LV mechanics.
The investigators are not completely clear in terms
of exclusion criteria. It seems that hypertensive
patients with some common comorbidities, such as
diabetes, obesity, and metabolic syndrome, were not
excluded from the study. Investigations have previ-
ously shown that these risk factors are associated with
cardiac extracellular matrix (2), and our study group
demonstrated that these cardiovascular risk factors
were associated with impairment of LV mechanics and
increased LV mass (3). Therefore, inclusion of these
risk factors certainly affects the relationship betweenECV and LV mechanics. It would be useful to compare
the levels of glucose and lipids, as well as body mass
index, among the groups.
The investigators included patients with LV ejec-
tion fractions >45%, but they did not provide values
of ejection fraction in different groups. Previous in-
vestigations have shown a strong correlation between
LV mechanics and LV ejection fraction in hyperten-
sive populations. Collins et al. (4) recently reported
that ECV fraction was more closely associated with
altered regional LV velocities than LV ejection fraction
in patients with preserved ejection fraction, while
Kuruvilla et al. (1) in the present study reveal the as-
sociation between ECV and LV mechanics, without
determination of the relation between ECV and LV
ejection fraction. These ﬁndings may have opened a
new era of LV function evaluation. Can we overcome
LV ejection fraction in modern cardiac imaging?
Additionally, it would be interesting to investigate
ECV in patients with different LVH patterns, con-
centric and eccentric. Previous studies have demon-
strated signiﬁcantly decreased 2-dimensional LV
longitudinal, circumferential, and radial strain in hy-
pertensive patients with concentric LVH com-
pared with subjects with eccentric hypertrophy (5).
The ﬁndings of the present study would potentially
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